200 related articles for article (PubMed ID: 2239488)
1. Inhibitors of dopamine inactivating systems as antiparkinson drugs.
Youdim MB
Adv Neurol; 1990; 53():483-8. PubMed ID: 2239488
[No Abstract] [Full Text] [Related]
2. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
[No Abstract] [Full Text] [Related]
3. New drugs in the treatment of Parkinson's disease. An introduction.
Bracco F
Adv Neurol; 1996; 69():513-7. PubMed ID: 8615173
[No Abstract] [Full Text] [Related]
4. Drugs for Parkinson's disease.
Cranwell-Bruce LA
Medsurg Nurs; 2010; 19(6):347-9, 355; quiz 350. PubMed ID: 21337993
[No Abstract] [Full Text] [Related]
5. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
Danisi F
Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacotherapeutic treatment options in Parkinson's disease.
Rezak M
Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.
Silver DE
Director; 2007; 15(2):20-9. PubMed ID: 19343903
[No Abstract] [Full Text] [Related]
8. Off spells and dyskinesias: pharmacologic management of motor complications.
Khan TS
Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S8-13. PubMed ID: 22761271
[TBL] [Abstract][Full Text] [Related]
9. [What strategies are recommended for early stage disease? Other treatments].
Damier P
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():105-8. PubMed ID: 10916044
[No Abstract] [Full Text] [Related]
10. [Antiparkinsonian drugs (author's transl)].
Ando K
No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
[No Abstract] [Full Text] [Related]
11. Other pharmacological treatments for motor complications and dyskinesias.
Waters C
Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of motor symptoms in Parkinson's disease].
Morís-De la Tassa G; Arias-Rodríguez M
Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease; modern treatment.
Tolosa E
Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
[No Abstract] [Full Text] [Related]
14. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
15. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185
[No Abstract] [Full Text] [Related]
16. [Drug therapy of Parkinson's disease].
Myllylä V
Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076
[No Abstract] [Full Text] [Related]
17. Drug selection and timing of initiation of treatment in early Parkinson's disease.
Schapira AH; Olanow CW
Ann Neurol; 2008 Dec; 64 Suppl 2():S47-55. PubMed ID: 19127579
[TBL] [Abstract][Full Text] [Related]
18. Future therapies for Parkinson's disease.
Hauser RA; Lyons KE
Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
[No Abstract] [Full Text] [Related]
19. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
[TBL] [Abstract][Full Text] [Related]
20. How should we treat a patient with early Parkinson's disease?
Tsouli S; Konitsiotis S
Int J Clin Pract; 2010 Aug; 64(9):1210-9. PubMed ID: 20653797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
